Latobest Eye Drop contains Latanoprost 0.005% w/v, a prostaglandin F2α analogue indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. Latanoprost acts by increasing the outflow of aqueous humor through the uveoscleral pathway, thereby effectively lowering IOP. This reduction in pressure helps to prevent damage to the optic nerve and loss of visual field associated with glaucoma. Latobest Eye Drop is administered topically, typically one drop in the affected eye(s) once daily in the evening. It is important to adhere to the prescribed dosage and avoid contact with the tip of the dropper to maintain sterility. Common adverse effects may include ocular hyperemia, eyelash growth, iris pigmentation changes, and mild ocular irritation. Patients should be monitored regularly for intraocular pressure and potential side effects during therapy. Latobest Eye Drop is contraindicated in patients with hypersensitivity to Latanoprost or any component of the formulation. Caution is advised in patients with a history of ocular inflammation or herpetic keratitis. This medication should be used under the supervision of an ophthalmologist to ensure optimal therapeutic outcomes and safety.